Clinical Trial Update: QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection [Phase 4]

View source ↗

Summary

The QUALITE study evaluated enfuvirtide (Fuzeon) in treatment-experienced HIV-1 patients in Phase 4, and the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Fuzeon (enfuvirtide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: HIV Infections | Phase 4 | Status: COMPLETED